Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the clinical trials.
Qichuan DengYu HuangJing ZengXinyu LiXianyi ZhengLi GuoJianyou ShiLan BaiPublished in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2024)
By revealing their structure-activity relationships, pharmacological actions, and clinical trials, small-molecule drugs can offer broad prospects for the development of new medications.